相关实验视频

Updated: May 25, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K

克劳丁18.2不是前列腺癌向免疫治疗的有前途的生物标志物

Jina Baek1, Young Ran Shim2, Mi-Jin Gu3

  • 1Department of Pathology, Samkwang Medical Lab, Seoul, Republic of Korea.

In vivo (Athens, Greece)
|February 26, 2025
PubMed
概括

克劳丁18.2 (CLDN18.2) 在前列腺癌组织中没有表达. 这一发现表明CLDN18.2不太可能成为前列腺癌免疫治疗的预后标记物或治疗标.

关键词:
生物标志物生物标志物克劳迪因 18.2 克劳迪因前列腺癌是前列腺癌.治疗目标是治疗的目标.

更多相关视频

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.6K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K